VCYTVERACYTE, INC.
- Market cap
- $3.85B
- as of 2026-10-23
- Latest close
- $47.93
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Diagnostics & Research
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-04
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Bhanji Muna | Oct 19 | Oct 20 | S | 1,864 | $43.70 | Sale −$81,457 | 40,854 | Yes | Form 4 |
| Leite JohnGlobal Chief Commercial Off | Sep 21 | Sep 22 | S | 4,015 | $40.00 | Sale −$160,600 | 124,329 | Yes | Form 4 |
| Holstein Jens | Sep 14 | Sep 16 | S | 5,000 | $40.95 | Sale −$204,750 | 27,471 | Yes | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Sep 4 | Sep 4 | S | 10,405 | $42.89 | Sale −$446,270 | 135,753 | Yes | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Sep 4 | Sep 4 | S | 2,705 | $43.66 | Sale −$118,100 | 133,048 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Sep 4 | Sep 4 | S | 2,477 | $42.81 | Sale −$106,040 | 167,200 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Sep 4 | Sep 4 | S | 1,175 | $43.71 | Sale −$51,359 | 166,025 | Yes | Form 4 |
| McGuire AnnieEVP, General Counsel | Sep 4 | Sep 4 | S | 2,154 | $42.79 | Sale −$92,170 | 132,260 | Yes | Form 4 |
| McGuire AnnieEVP, General Counsel | Sep 4 | Sep 4 | S | 1,100 | $43.67 | Sale −$48,037 | 131,160 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Sep 2 | Sep 4 | F | 8,782 | $44.88 | $394,136 | 432,073 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Sep 2 | Sep 4 | F | 1,361 | $44.88 | $61,082 | 43,226 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Sep 2 | Sep 4 | F | 3,639 | $44.88 | $163,318 | 146,158 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Sep 2 | Sep 4 | F | 3,603 | $44.88 | $161,703 | 169,677 | Yes | Form 4 |
| McGuire AnnieEVP, General Counsel | Sep 2 | Sep 4 | F | 3,215 | $44.88 | $144,289 | 134,414 | Yes | Form 4 |
| Leite JohnGlobal Chief Commercial Off | Sep 2 | Sep 4 | F | 3,961 | $44.88 | $177,770 | 128,344 | No | Form 4 |
| Bhanji Muna | Sep 1 | Sep 3 | S | 1,864 | $42.97 | Sale −$80,096 | 42,718 | Yes | Form 4 |
| Eastham Karin | Jun 18 | Jun 22 | S | 3,200 | $52.78 | Sale −$168,896 | 15,626 | Yes | Form 4 |
| Eastham Karin | Jun 18 | Jun 22 | S | 529 | $53.55 | Sale −$28,328 | 15,097 | Yes | Form 4 |
| Jones Evan/ Fa | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 34,634 | No | Form 4 |
| Eastham Karin | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 18,826 | No | Form 4 |
| Epstein Robert S | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 57,718 | No | Form 4 |
| Shafer David Brent | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 31,100 | No | Form 4 |
| Holstein Jens | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 32,471 | No | Form 4 |
| Bhanji Muna | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 44,582 | No | Form 4 |
| Barr Eliav | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 56,461 | No | Form 4 |
| Miller Thomas F. | Jun 11 | Jun 15 | A | 5,272 | $0.00 | $0 | 31,100 | No | Form 4 |
| Stapley MarcChief Executive Officer | Jun 4 | Jun 4 | M | 138,051 | $36.60 | $5,052,667 | 578,545 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Jun 4 | Jun 4 | S | 138,051 | $50.12 | Sale −$6,919,116 | 440,494 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Jun 4 | Jun 4 | M · derivative | 138,051 | $36.60 | $5,052,667 | not reported | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Jun 4 | Jun 4 | S | 1,600 | $49.28 | Sale −$78,848 | 175,241 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Jun 4 | Jun 4 | S | 1,961 | $50.09 | Sale −$98,226 | 173,280 | Yes | Form 4 |
| McGuire AnnieEVP, General Counsel | Jun 4 | Jun 4 | S | 1,400 | $49.31 | Sale −$69,034 | 139,016 | Yes | Form 4 |
| McGuire AnnieEVP, General Counsel | Jun 4 | Jun 4 | S | 1,776 | $50.12 | Sale −$89,013 | 137,240 | Yes | Form 4 |
| Leite JohnGlobal Chief Commercial Off | Jun 4 | Jun 4 | S | 13,975 | $50.07 | Sale −$699,728 | 132,305 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Jun 2 | Jun 4 | F | 9,012 | $47.80 | $430,774 | 440,494 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Jun 2 | Jun 4 | F | 1,361 | $47.80 | $65,056 | 44,073 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Jun 2 | Jun 4 | F | 3,730 | $47.80 | $178,294 | 149,797 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Jun 2 | Jun 4 | F | 3,693 | $47.80 | $176,525 | 176,841 | Yes | Form 4 |
| McGuire AnnieEVP, General Counsel | Jun 2 | Jun 4 | F | 3,292 | $47.80 | $157,358 | 140,416 | Yes | Form 4 |
| Leite JohnGlobal Chief Commercial Off | Jun 2 | Jun 4 | F | 4,059 | $47.80 | $194,020 | 146,280 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | May 22 | May 27 | M | 24,000 | $24.80 | $595,200 | 69,434 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | May 22 | May 27 | S | 24,000 | $45.40 | Sale −$1,089,600 | 45,434 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | May 22 | May 27 | M · derivative | 24,000 | $24.80 | $595,200 | not reported | No | Form 4 |
| Epstein Robert S | May 20 | May 22 | S | 10,000 | $44.01 | Sale −$440,100 | 52,446 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | May 6 | May 8 | S | 5,102 | $38.05 | Sale −$194,131 | 148,810 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | May 6 | May 8 | S | 5,102 | $40.00 | Sale −$204,080 | 143,708 | Yes | Form 4 |
| Haas Kevin RichardChief Dev and Tech Officer | Apr 10 | Apr 14 | A | 44,221 | $0.00 | $0 | 44,221 | No | Form 4 |
| Stapley MarcChief Executive Officer | Mar 6 | Mar 10 | A | 92,099 | $0.00 | $0 | 449,653 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Mar 6 | Mar 10 | A | 10,525 | $0.00 | $0 | 45,434 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 6 | Mar 10 | A | 29,603 | $0.00 | $0 | 146,949 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 6 | Mar 10 | A | 6,578 | $0.00 | $0 | 153,527 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 6 | Mar 10 | A | 36,181 | $0.00 | $0 | 167,377 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 6 | Mar 10 | A | 13,157 | $0.00 | $0 | 180,534 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 6 | Mar 10 | A | 32,892 | $0.00 | $0 | 127,598 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 6 | Mar 10 | A | 26,314 | $0.00 | $0 | 153,912 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 6 | Mar 10 | A | 36,181 | $0.00 | $0 | 143,761 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 6 | Mar 10 | A | 6,578 | $0.00 | $0 | 150,339 | No | Form 4 |
| Stapley MarcChief Executive Officer | Mar 4 | Mar 6 | S | 19,244 | $35.56 | Sale −$684,317 | 383,833 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Mar 4 | Mar 6 | S | 26,279 | $36.28 | Sale −$953,402 | 357,554 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 4 | Mar 6 | S | 4,400 | $35.55 | Sale −$156,420 | 145,137 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 4 | Mar 6 | S | 13,941 | $36.33 | Sale −$506,477 | 131,196 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 4 | Mar 6 | S | 4,994 | $35.29 | Sale −$176,238 | 96,370 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 4 | Mar 6 | S | 1,664 | $36.34 | Sale −$60,470 | 94,706 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 4 | Mar 6 | S | 5,260 | $35.19 | Sale −$185,099 | 107,580 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Mar 2 | Mar 4 | F | 19,455 | $36.01 | $700,575 | 403,077 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Mar 2 | Mar 4 | F | 3,006 | $36.01 | $108,246 | 34,909 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 2 | Mar 4 | F | 6,035 | $36.01 | $217,320 | 130,771 | Yes | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 2 | Mar 4 | S | 13,425 | $36.16 | Sale −$485,448 | 117,346 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 2 | Mar 4 | F | 7,234 | $36.01 | $260,496 | 149,537 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 2 | Mar 4 | F | 6,902 | $36.01 | $248,541 | 101,364 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 2 | Mar 4 | F | 7,517 | $36.01 | $270,687 | 112,840 | No | Form 4 |
| Stapley MarcChief Executive Officer | Feb 26 | Mar 2 | A | 139,074 | $0.00 | $0 | 458,373 | No | Form 4 |
| Stapley MarcChief Executive Officer | Feb 26 | Mar 2 | F | 35,841 | $38.75 | $1,388,839 | 422,532 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Feb 26 | Mar 2 | A | 71,806 | $0.00 | $0 | 161,292 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Feb 26 | Mar 2 | F | 24,486 | $38.75 | $948,833 | 136,806 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Feb 26 | Mar 2 | A | 59,324 | $0.00 | $0 | 168,820 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Feb 26 | Mar 2 | F | 12,049 | $38.75 | $466,899 | 156,771 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Feb 26 | Mar 2 | A | 50,999 | $0.00 | $0 | 119,133 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Feb 26 | Mar 2 | F | 10,867 | $38.75 | $421,096 | 108,266 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Feb 26 | Mar 2 | A | 47,149 | $0.00 | $0 | 129,262 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Feb 26 | Mar 2 | F | 8,905 | $38.75 | $345,069 | 120,357 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 16, 2025 | Dec 17, 2025 | S | 10,639 | $43.13 | Sale −$458,860 | 67,860 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 16, 2025 | Dec 17, 2025 | S | 100 | $43.68 | Sale −$4,368 | 67,760 | Yes | Form 4 |
| Eastham Karin | Dec 5, 2025 | Dec 8, 2025 | M | 10,000 | $7.94 | $79,400 | 23,554 | Yes | Form 4 |
| Eastham Karin | Dec 5, 2025 | Dec 8, 2025 | M | 10,000 | $7.60 | $76,000 | 33,554 | Yes | Form 4 |
| Eastham Karin | Dec 5, 2025 | Dec 8, 2025 | S | 6,392 | $44.52 | Sale −$284,572 | 27,162 | Yes | Form 4 |
| Eastham Karin | Dec 5, 2025 | Dec 8, 2025 | S | 12,808 | $45.84 | Sale −$587,119 | 14,354 | Yes | Form 4 |
| Eastham Karin | Dec 5, 2025 | Dec 8, 2025 | S | 800 | $46.59 | Sale −$37,272 | 13,554 | Yes | Form 4 |
| Eastham Karin | Dec 5, 2025 | Dec 8, 2025 | M · derivative | 10,000 | $7.94 | $79,400 | not reported | Yes | Form 4 |
| Eastham Karin | Dec 5, 2025 | Dec 8, 2025 | M · derivative | 10,000 | $7.60 | $76,000 | not reported | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Dec 4, 2025 | Dec 4, 2025 | S | 4,448 | $46.90 | Sale −$208,611 | 321,823 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Dec 4, 2025 | Dec 4, 2025 | S | 3,220 | $47.35 | Sale −$152,467 | 318,603 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Dec 4, 2025 | Dec 4, 2025 | S | 8,537 | $46.61 | Sale −$397,910 | 114,237 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Dec 4, 2025 | Dec 4, 2025 | S | 4,741 | $47.25 | Sale −$224,012 | 109,496 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 4, 2025 | Dec 4, 2025 | S | 720 | $47.10 | Sale −$33,912 | 79,201 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 4, 2025 | Dec 4, 2025 | S | 702 | $47.51 | Sale −$33,352 | 78,499 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Dec 4, 2025 | Dec 4, 2025 | S | 1,278 | $47.51 | Sale −$60,718 | 82,113 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Dec 2, 2025 | Dec 4, 2025 | F | 7,914 | $46.16 | $365,310 | 326,271 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Dec 2, 2025 | Dec 4, 2025 | F | 1,325 | $46.16 | $61,162 | 37,420 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Dec 2, 2025 | Dec 4, 2025 | F | 2,955 | $46.16 | $136,403 | 89,486 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Dec 2, 2025 | Dec 4, 2025 | F | 3,384 | $46.16 | $156,205 | 122,774 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 2, 2025 | Dec 4, 2025 | F | 3,052 | $46.16 | $140,880 | 79,921 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Dec 2, 2025 | Dec 4, 2025 | F | 2,900 | $46.16 | $133,864 | 83,391 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 25, 2025 | Nov 26, 2025 | S | 1,106 | $50.25 | Sale −$55,577 | 29,362 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Nov 25, 2025 | Nov 26, 2025 | S | 2,808 | $50.00 | Sale −$140,400 | 86,291 | Yes | Form 4 |
| Holstein Jens | Nov 20, 2025 | Nov 21, 2025 | S | 1,491 | $40.95 | Sale −$61,056 | 35,708 | Yes | Form 4 |
| Holstein Jens | Nov 20, 2025 | Nov 21, 2025 | S | 7,049 | $42.48 | Sale −$299,442 | 28,659 | Yes | Form 4 |
| Holstein Jens | Nov 20, 2025 | Nov 21, 2025 | S | 1,460 | $43.21 | Sale −$63,087 | 27,199 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Nov 10, 2025 | Nov 12, 2025 | S | 5,102 | $42.33 | Sale −$215,968 | 38,745 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Nov 7, 2025 | Nov 12, 2025 | S | 5,818 | $40.21 | Sale −$233,942 | 43,847 | No | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | M | 10,000 | $5.28 | $52,800 | 53,664 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | M | 10,000 | $7.94 | $79,400 | 63,664 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | M | 10,000 | $7.60 | $76,000 | 73,664 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | S | 408 | $41.74 | Sale −$17,030 | 73,256 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | S | 1,126 | $43.03 | Sale −$48,452 | 72,130 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | S | 10,837 | $43.80 | Sale −$474,661 | 61,293 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | S | 5,872 | $45.07 | Sale −$264,651 | 55,421 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | S | 24,296 | $45.73 | Sale −$1,111,056 | 31,125 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | S | 657 | $46.38 | Sale −$30,472 | 30,468 | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | M · derivative | 10,000 | $5.28 | $52,800 | not reported | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | M · derivative | 10,000 | $7.94 | $79,400 | not reported | Yes | Form 4 |
| Jones Evan/ Fa | Nov 5, 2025 | Nov 7, 2025 | M · derivative | 10,000 | $7.60 | $76,000 | not reported | Yes | Form 4 |
| Eastham Karin | Nov 5, 2025 | Nov 7, 2025 | S | 9,674 | $40.02 | Sale −$387,153 | 13,554 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Nov 5, 2025 | Nov 7, 2025 | S | 7,000 | $41.00 | Sale −$287,000 | 126,158 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Nov 5, 2025 | Nov 7, 2025 | S | 6,466 | $40.00 | Sale −$258,640 | 82,973 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Oct 28, 2025 | Oct 30, 2025 | A | 2,886 | $0.00 | $0 | 49,665 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Oct 6, 2025 | Oct 7, 2025 | S | 8,349 | $36.02 | Sale −$300,731 | 92,441 | Yes | Form 4 |
| Epstein Robert S | Oct 1, 2025 | Oct 3, 2025 | M | 10,000 | $7.94 | $79,400 | 83,919 | Yes | Form 4 |
| Epstein Robert S | Oct 1, 2025 | Oct 3, 2025 | S | 21,473 | $35.08 | Sale −$753,273 | 62,446 | Yes | Form 4 |
| Epstein Robert S | Oct 1, 2025 | Oct 3, 2025 | M · derivative | 10,000 | $7.94 | $79,400 | not reported | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Oct 1, 2025 | Oct 3, 2025 | S | 2,160 | $35.00 | Sale −$75,600 | 89,439 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Oct 1, 2025 | Oct 3, 2025 | S | 2,539 | $35.00 | Sale −$88,865 | 89,099 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Sep 19, 2025 | Sep 23, 2025 | S | 2,283 | $33.69 | Sale −$76,914 | 91,599 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Sep 4, 2025 | Sep 8, 2025 | S | 7,667 | $30.41 | Sale −$233,153 | 334,185 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Sep 2, 2025 | Sep 4, 2025 | F | 1,648 | $30.11 | $49,621 | 46,779 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Sep 2, 2025 | Sep 4, 2025 | F | 2,902 | $30.11 | $87,379 | 91,638 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Sep 2, 2025 | Sep 4, 2025 | F | 2,955 | $30.11 | $88,975 | 100,790 | No | Form 4 |
| Stapley MarcChief Executive Officer | Sep 2, 2025 | Sep 4, 2025 | F | 7,914 | $30.11 | $238,291 | 341,852 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Sep 2, 2025 | Sep 4, 2025 | F | 3,507 | $30.11 | $105,596 | 93,882 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Sep 2, 2025 | Sep 4, 2025 | F | 5,371 | $30.11 | $161,721 | 133,158 | No | Form 4 |
| Shafer David Brent | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 25,828 | No | Form 4 |
| Miller Thomas F. | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 25,828 | No | Form 4 |
| Bhanji Muna | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 39,310 | No | Form 4 |
| Barr Eliav | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 51,189 | No | Form 4 |
| Epstein Robert S | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 73,919 | No | Form 4 |
| Jones Evan/ Fa | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 43,664 | No | Form 4 |
| Holstein Jens | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 37,199 | No | Form 4 |
| Eastham Karin | Jun 18, 2025 | Jun 23, 2025 | A | 9,321 | $0.00 | $0 | 23,228 | No | Form 4 |
| Bhanji Muna | Jun 13, 2025 | Jun 17, 2025 | S | 4,589 | $26.67 | Sale −$122,389 | 29,989 | Yes | Form 4 |
| Eastham Karin | Jun 13, 2025 | Jun 17, 2025 | S | 4,590 | $26.66 | Sale −$122,369 | 13,907 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Jun 4, 2025 | Jun 6, 2025 | S | 2,809 | $27.20 | Sale −$76,405 | 94,540 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Jun 2, 2025 | Jun 4, 2025 | F | 9,399 | $26.74 | $251,329 | 349,237 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Jun 2, 2025 | Jun 4, 2025 | F | 2,955 | $26.74 | $79,017 | 103,745 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Jun 2, 2025 | Jun 4, 2025 | F | 1,848 | $26.74 | $49,416 | 47,915 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Jun 2, 2025 | Jun 4, 2025 | F | 2,900 | $26.74 | $77,546 | 97,349 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Jun 2, 2025 | Jun 4, 2025 | F | 5,370 | $26.74 | $143,594 | 138,529 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Jun 2, 2025 | Jun 4, 2025 | F | 3,505 | $26.74 | $93,724 | 97,003 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 7, 2025 | Mar 10, 2025 | S | 2,400 | $31.04 | Sale −$74,496 | 105,260 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 7, 2025 | Mar 10, 2025 | S | 5,011 | $31.96 | Sale −$160,152 | 100,249 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Mar 6, 2025 | Mar 10, 2025 | A | 90,601 | $0.00 | $0 | 358,636 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 6, 2025 | Mar 10, 2025 | A | 30,200 | $0.00 | $0 | 100,508 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 6, 2025 | Mar 10, 2025 | A | 36,240 | $0.00 | $0 | 107,660 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 6, 2025 | Mar 10, 2025 | A | 30,200 | $0.00 | $0 | 143,899 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 6, 2025 | Mar 10, 2025 | A | 24,160 | $0.00 | $0 | 106,700 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Mar 6, 2025 | Mar 10, 2025 | A | 13,288 | $0.00 | $0 | 49,763 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 4, 2025 | Mar 6, 2025 | S | 1,142 | $33.69 | Sale −$38,474 | 70,308 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Mar 4, 2025 | Mar 6, 2025 | S | 28,189 | $32.82 | Sale −$925,163 | 292,543 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Mar 4, 2025 | Mar 6, 2025 | S | 23,414 | $33.91 | Sale −$793,969 | 269,129 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Mar 4, 2025 | Mar 6, 2025 | S | 1,094 | $34.37 | Sale −$37,601 | 268,035 | Yes | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 4, 2025 | Mar 6, 2025 | S | 4,467 | $32.86 | Sale −$146,786 | 86,110 | Yes | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 4, 2025 | Mar 6, 2025 | S | 3,570 | $33.95 | Sale −$121,202 | 82,540 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 2, 2025 | Mar 3, 2025 | F | 8,255 | $34.76 | $286,944 | 71,450 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 2, 2025 | Mar 3, 2025 | F | 11,070 | $34.76 | $384,793 | 113,699 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Mar 2, 2025 | Mar 3, 2025 | F | 4,301 | $34.76 | $149,503 | 36,475 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 2, 2025 | Mar 3, 2025 | F | 6,754 | $34.76 | $234,769 | 90,577 | No | Form 4 |
| Stapley MarcChief Executive Officer | Mar 2, 2025 | Mar 3, 2025 | F | 20,324 | $34.76 | $706,462 | 320,732 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 2, 2025 | Mar 3, 2025 | F | 7,650 | $34.76 | $265,914 | 71,420 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Feb 27, 2025 | Mar 3, 2025 | A | 13,466 | $0.00 | $0 | 86,705 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Feb 27, 2025 | Mar 3, 2025 | F | 7,000 | $33.84 | $236,880 | 79,705 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Feb 27, 2025 | Mar 3, 2025 | A | 23,170 | $0.00 | $0 | 136,680 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Feb 27, 2025 | Mar 3, 2025 | F | 11,911 | $33.84 | $403,068 | 124,769 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Feb 27, 2025 | Mar 3, 2025 | A | 30,589 | $0.00 | $0 | 113,003 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Feb 27, 2025 | Mar 3, 2025 | F | 15,672 | $33.84 | $530,340 | 97,331 | No | Form 4 |
| Stapley MarcChief Executive Officer | Feb 27, 2025 | Mar 3, 2025 | A | 67,277 | $0.00 | $0 | 375,329 | No | Form 4 |
| Stapley MarcChief Executive Officer | Feb 27, 2025 | Mar 3, 2025 | F | 34,273 | $33.84 | $1,159,798 | 341,056 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Feb 27, 2025 | Mar 3, 2025 | A | 11,006 | $0.00 | $0 | 84,816 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Feb 27, 2025 | Mar 3, 2025 | S | 5,746 | $33.84 | Sale −$194,445 | 79,070 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Feb 3, 2025 | Feb 5, 2025 | S | 527 | $43.85 | Sale −$23,109 | 113,510 | Yes | Form 4 |
| Epstein Robert S | Jan 6, 2025 | Jan 8, 2025 | M | 20,000 | $8.04 | $160,800 | 64,598 | No | Form 4 |
| Epstein Robert S | Jan 6, 2025 | Jan 8, 2025 | M · derivative | 20,000 | $8.04 | $160,800 | not reported | No | Form 4 |
| Eastham Karin | Jan 2, 2025 | Jan 6, 2025 | M | 10,000 | $5.28 | $52,800 | 28,497 | Yes | Form 4 |
| Eastham Karin | Jan 2, 2025 | Jan 6, 2025 | S | 5,309 | $40.12 | Sale −$212,997 | 23,188 | Yes | Form 4 |
| Eastham Karin | Jan 2, 2025 | Jan 6, 2025 | S | 4,691 | $40.50 | Sale −$189,986 | 18,497 | Yes | Form 4 |
| Eastham Karin | Jan 2, 2025 | Jan 6, 2025 | M · derivative | 10,000 | $5.28 | $52,800 | not reported | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Dec 13, 2024 | Dec 17, 2024 | S | 5,190 | $43.37 | Sale −$225,090 | 307,745 | Yes | Form 4 |
| Stapley MarcChief Executive Officer | Dec 13, 2024 | Dec 17, 2024 | S | 400 | $44.14 | Sale −$17,656 | 307,345 | Yes | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 4, 2024 | Dec 6, 2024 | S | 18,699 | $44.02 | Sale −$823,130 | 72,869 | Yes | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Dec 4, 2024 | Dec 6, 2024 | S | 3,934 | $44.09 | Sale −$173,450 | 82,414 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Dec 3, 2024 | Dec 4, 2024 | S | 956 | $43.36 | Sale −$41,452 | 40,270 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Dec 3, 2024 | Dec 4, 2024 | S | 7,000 | $43.23 | Sale −$302,610 | 114,037 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Dec 3, 2024 | Dec 4, 2024 | S | 1,050 | $43.25 | Sale −$45,413 | 73,810 | No | Form 4 |
| Stapley MarcChief Executive Officer | Dec 2, 2024 | Dec 4, 2024 | F | 5,748 | $44.12 | $253,602 | 312,935 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Dec 2, 2024 | Dec 4, 2024 | F | 1,087 | $44.12 | $47,958 | 41,226 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Dec 2, 2024 | Dec 4, 2024 | F | 6,738 | $44.12 | $297,281 | 86,348 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Dec 2, 2024 | Dec 4, 2024 | F | 3,464 | $44.12 | $152,832 | 121,037 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Dec 2, 2024 | Dec 4, 2024 | F | 1,314 | $44.12 | $57,974 | 74,860 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 2, 2024 | Dec 4, 2024 | F | 1,918 | $44.12 | $84,622 | 91,568 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Nov 27, 2024 | Nov 29, 2024 | S | 5,032 | $42.89 | Sale −$215,822 | 42,313 | No | Form 4 |
| Eastham Karin | Nov 19, 2024 | Nov 21, 2024 | S | 1,600 | $36.77 | Sale −$58,832 | 31,628 | Yes | Form 4 |
| Eastham Karin | Nov 19, 2024 | Nov 21, 2024 | S | 3,006 | $37.77 | Sale −$113,537 | 28,622 | Yes | Form 4 |
| Eastham Karin | Nov 19, 2024 | Nov 21, 2024 | S | 10,125 | $38.76 | Sale −$392,445 | 18,497 | Yes | Form 4 |
| Epstein Robert S | Nov 12, 2024 | Nov 14, 2024 | M | 15,000 | $8.04 | $120,600 | 59,598 | Yes | Form 4 |
| Epstein Robert S | Nov 12, 2024 | Nov 14, 2024 | S | 15,000 | $38.32 | Sale −$574,800 | 44,598 | Yes | Form 4 |
| Epstein Robert S | Nov 12, 2024 | Nov 14, 2024 | M · derivative | 15,000 | $8.04 | $120,600 | 20,000 | Yes | Form 4 |
| Chambers RebeccaChief Financial Officer | Nov 12, 2024 | Nov 14, 2024 | S | 15,275 | $38.34 | Sale −$585,644 | 124,501 | Yes | Form 4 |
| Jones Evan/ Fa | Sep 19, 2024 | Sep 23, 2024 | S | 5,173 | $35.23 | Sale −$182,245 | not reported | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Sep 4, 2024 | Sep 6, 2024 | S | 5,479 | $29.78 | Sale −$163,165 | 76,174 | Yes | Form 4 |
| Shafer David Brent | Sep 3, 2024 | Sep 4, 2024 | A | 16,507 | $0.00 | $0 | 16,507 | No | Form 4 |
| Miller Thomas F. | Sep 3, 2024 | Sep 4, 2024 | A | 16,507 | $0.00 | $0 | 16,507 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Sep 2, 2024 | Sep 4, 2024 | F | 1,315 | $31.55 | $41,488 | 81,653 | No | Form 4 |
| Stapley MarcChief Executive Officer | Sep 2, 2024 | Sep 4, 2024 | F | 5,748 | $31.55 | $181,349 | 318,683 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Sep 2, 2024 | Sep 4, 2024 | F | 1,087 | $31.55 | $34,295 | 47,345 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Sep 2, 2024 | Sep 4, 2024 | F | 1,920 | $31.55 | $60,576 | 93,486 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Sep 2, 2024 | Sep 4, 2024 | F | 3,464 | $31.55 | $109,289 | 139,776 | No | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | M | 8,486 | $10.41 | $88,339 | 54,800 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | S | 2,931 | $31.19 | Sale −$91,418 | 51,869 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | S | 16,838 | $32.36 | Sale −$544,878 | 35,031 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | S | 688 | $32.77 | Sale −$22,546 | 34,343 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | S | 3,869 | $31.19 | Sale −$120,674 | 28,492 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | S | 22,407 | $32.36 | Sale −$725,091 | 6,085 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | S | 912 | $32.77 | Sale −$29,886 | 5,173 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 13, 2024 | Aug 14, 2024 | M · derivative | 8,486 | $10.41 | $88,339 | not reported | Yes | Form 4 |
| Jones Evan/ Fa | Aug 12, 2024 | Aug 14, 2024 | S | 99 | $30.01 | Sale −$2,971 | 46,314 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 12, 2024 | Aug 14, 2024 | S | 101 | $30.01 | Sale −$3,031 | 32,361 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 9, 2024 | Aug 13, 2024 | M | 300 | $10.41 | $3,123 | 47,445 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 9, 2024 | Aug 13, 2024 | S | 1,032 | $30.03 | Sale −$30,991 | 46,413 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 9, 2024 | Aug 13, 2024 | S | 746 | $30.03 | Sale −$22,402 | 32,462 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 9, 2024 | Aug 13, 2024 | M · derivative | 300 | $10.41 | $3,123 | 8,486 | Yes | Form 4 |
| Jones Evan/ Fa | Aug 7, 2024 | Aug 13, 20244/A | S | 3,143 | $30.32 | Sale −$95,296 | 47,145 | Yes | Form 4/A |
| Jones Evan/ Fa | Aug 7, 2024 | Aug 13, 20244/A | S | 1,965 | $30.32 | Sale −$59,579 | 33,208 | Yes | Form 4/A |
| Holstein Jens | Aug 7, 2024 | Aug 9, 2024 | S | 2,500 | $28.00 | Sale −$70,000 | 30,378 | Yes | Form 4 |
| Holstein Jens | Aug 7, 2024 | Aug 9, 2024 | S | 2,500 | $30.00 | Sale −$75,000 | 27,878 | Yes | Form 4 |
| Holstein Jens | Jul 16, 2024 | Jul 18, 2024 | S | 2,500 | $24.00 | Sale −$60,000 | 35,378 | Yes | Form 4 |
| Holstein Jens | Jul 16, 2024 | Jul 18, 2024 | S | 2,500 | $25.00 | Sale −$62,500 | 32,878 | Yes | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Jul 16, 2024 | Jul 18, 2024 | S | 1,277 | $25.00 | Sale −$31,925 | 82,968 | Yes | Form 4 |
| Eastham Karin | Jul 16, 2024 | Jul 18, 2024 | S | 7,500 | $25.00 | Sale −$187,500 | 33,228 | Yes | Form 4 |
| Eastham Karin | Jun 13, 2024 | Jun 17, 2024 | A | 11,473 | $0.00 | $0 | 40,728 | No | Form 4 |
| Epstein Robert S | Jun 13, 2024 | Jun 17, 2024 | A | 11,473 | $0.00 | $0 | 44,598 | No | Form 4 |
| Bhanji Muna | Jun 13, 2024 | Jun 17, 2024 | A | 11,473 | $0.00 | $0 | 34,578 | No | Form 4 |
| Holstein Jens | Jun 13, 2024 | Jun 17, 2024 | A | 11,473 | $0.00 | $0 | 37,878 | No | Form 4 |
| Barr Eliav | Jun 13, 2024 | Jun 17, 2024 | A | 11,473 | $0.00 | $0 | 41,868 | No | Form 4 |
| Jones Evan/ Fa | Jun 13, 2024 | Jun 17, 2024 | A | 11,473 | $0.00 | $0 | 49,074 | No | Form 4 |
| Eastham Karin | Jun 11, 2024 | Jun 13, 2024 | S | 3,870 | $20.59 | Sale −$79,683 | 29,255 | Yes | Form 4 |
| Bhanji Muna | Jun 10, 2024 | Jun 11, 2024 | S | 3,870 | $20.32 | Sale −$78,638 | 23,105 | Yes | Form 4 |
| Eastham Karin | Jun 7, 2024 | Jun 11, 2024 | M | 2,500 | $10.41 | $26,025 | 35,625 | Yes | Form 4 |
| Eastham Karin | Jun 7, 2024 | Jun 11, 2024 | S | 2,500 | $20.97 | Sale −$52,425 | 33,125 | Yes | Form 4 |
| Eastham Karin | Jun 7, 2024 | Jun 11, 2024 | M · derivative | 2,500 | $10.41 | $26,025 | 7,500 | Yes | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Jun 2, 2024 | Jun 4, 2024 | F | 1,087 | $20.75 | $22,555 | 47,971 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Jun 2, 2024 | Jun 4, 2024 | F | 1,314 | $20.75 | $27,266 | 84,245 | No | Form 4 |
| Stapley MarcChief Executive Officer | Jun 2, 2024 | Jun 4, 2024 | F | 5,746 | $20.75 | $119,230 | 323,994 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Jun 2, 2024 | Jun 4, 2024 | F | 1,919 | $20.75 | $39,819 | 95,406 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Jun 2, 2024 | Jun 4, 2024 | F | 3,462 | $20.75 | $71,837 | 143,240 | No | Form 4 |
| Bhanji Muna | May 28, 2024 | May 30, 2024 | S | 1,539 | $21.00 | Sale −$32,319 | 26,975 | Yes | Form 4 |
| Eastham Karin | Apr 1, 2024 | Apr 2, 2024 | M | 10,000 | $13.19 | $131,900 | 43,125 | No | Form 4 |
| Eastham Karin | Apr 1, 2024 | Apr 2, 2024 | S | 10,000 | $21.65 | Sale −$216,500 | 33,125 | No | Form 4 |
| Eastham Karin | Apr 1, 2024 | Apr 2, 2024 | M · derivative | 10,000 | $13.19 | $131,900 | not reported | No | Form 4 |
| Stapley MarcChief Executive Officer | Mar 15, 2024 | Mar 19, 2024 | A | 11,780 | $0.00 | $0 | 335,711 | No | Form 4 |
| Stapley MarcChief Executive Officer | Mar 15, 2024 | Mar 19, 2024 | F | 5,971 | $21.10 | $125,988 | 329,740 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 15, 2024 | Mar 19, 2024 | A | 4,318 | $0.00 | $0 | 148,891 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 15, 2024 | Mar 19, 2024 | F | 2,189 | $21.10 | $46,188 | 146,702 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Mar 6, 2024 | Mar 8, 2024 | A | 39,904 | $0.00 | $0 | 93,086 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 6, 2024 | Mar 8, 2024 | A | 59,856 | $0.00 | $0 | 144,573 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Mar 6, 2024 | Mar 8, 2024 | A | 23,942 | $0.00 | $0 | 49,058 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 6, 2024 | Mar 8, 2024 | A | 49,880 | $0.00 | $0 | 97,325 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 6, 2024 | Mar 8, 2024 | A | 49,880 | $0.00 | $0 | 85,559 | No | Form 4 |
| Stapley MarcChief Executive Officer | Mar 6, 2024 | Mar 8, 2024 | A | 114,724 | $0.00 | $0 | 323,931 | No | Form 4 |
| Stapley MarcChief Executive Officer | Mar 2, 2024 | Mar 5, 2024 | F | 13,286 | $24.00 | $318,864 | 209,207 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Mar 2, 2024 | Mar 5, 2024 | F | 3,008 | $24.00 | $72,192 | 35,679 | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Mar 2, 2024 | Mar 5, 2024 | F | 6,112 | $24.00 | $146,688 | 84,717 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Mar 2, 2024 | Mar 5, 2024 | F | 2,337 | $24.00 | $56,088 | 25,116 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Mar 2, 2024 | Mar 5, 2024 | F | 4,347 | $24.00 | $104,328 | 47,445 | No | Form 4 |
| Jones Evan/ Fa | Mar 1, 2024 | Mar 5, 2024 | M | 10,000 | $13.19 | $131,900 | 47,601 | No | Form 4 |
| Jones Evan/ Fa | Mar 1, 2024 | Mar 5, 2024 | S | 10,000 | $24.36 | Sale −$243,600 | 37,601 | No | Form 4 |
| Jones Evan/ Fa | Mar 1, 2024 | Mar 5, 2024 | M · derivative | 10,000 | $13.19 | $131,900 | not reported | No | Form 4 |
| Chambers RebeccaChief Financial Officer | Dec 2, 2023 | Dec 5, 2023 | F | 1,800 | $26.54 | $47,772 | 90,829 | No | Form 4 |
| Leite JohnChief Commercial Officer-CLIA | Dec 2, 2023 | Dec 5, 2023 | F | 556 | $26.54 | $14,756 | 38,687 | No | Form 4 |
| Stapley MarcChief Executive Officer | Dec 2, 2023 | Dec 5, 2023 | F | 3,203 | $26.54 | $85,008 | 221,882 | No | Form 4 |
| Wygant JonathanVP, Chief Accounting Officer | Dec 2, 2023 | Dec 5, 2023 | F | 507 | $26.54 | $13,456 | 27,020 | No | Form 4 |
| McGuire AnnieSVP, General Counsel | Dec 2, 2023 | Dec 5, 2023 | F | 803 | $26.54 | $21,312 | 51,792 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Oct 2, 2023 | Oct 4, 2023 | A | 53,182 | $0.00 | $0 | 53,182 | No | Form 4 |
| Febbo Phillip G.Chief Scientific & Med Officer | Oct 2, 2023 | Oct 4, 2023 | A · derivative | 85,858 | $21.96 | $1,885,442 | 85,858 | No | Form 4 |